| Literature DB >> 26839579 |
Marta Vazquez-Vilar1, Joan Miquel Bernabé-Orts1, Asun Fernandez-Del-Carmen1, Pello Ziarsolo2, Jose Blanca2, Antonio Granell1, Diego Orzaez1.
Abstract
BACKGROUND: The efficiency, versatility and multiplexing capacity of RNA-guided genome engineering using the CRISPR/Cas9 technology enables a variety of applications in plants, ranging from gene editing to the construction of transcriptional gene circuits, many of which depend on the technical ability to compose and transfer complex synthetic instructions into the plant cell. The engineering principles of standardization and modularity applied to DNA cloning are impacting plant genetic engineering, by increasing multigene assembly efficiency and by fostering the exchange of well-defined physical DNA parts with precise functional information.Entities:
Keywords: CRISPR/Cas9; GoldenBraid; Luciferase/renilla assay; Multigenic assemblies; Plant gene activation; Plant gene editing; Plant gene repression; gRNAs
Year: 2016 PMID: 26839579 PMCID: PMC4736081 DOI: 10.1186/s13007-016-0101-2
Source DB: PubMed Journal: Plant Methods ISSN: 1746-4811 Impact factor: 4.993
Fig. 1Multiple guide RNAs assembly with GoldenBraid. a Software-assisted CRISPR cloning workflow. Targets are adapted to the GoldenBraid standard with the ‘GB-CRISPR domesticator’. Then, these level 0 parts (D/M-Targets) are combined with other standard GBparts with the ‘GB-CRISPR assembler’ to create the guide RNA expression cassettes, which can be combined between them and/or with a Cas9 transcriptional unit with the ‘GB-binary assembler’. b Optimization of GB-CRISPR multipartite reactions. Forward and reverse primers were diluted to different concentrations with different solvents; they were mixed and twelve independent multipartite reactions were set up. After transformation into E. coli, the number of colonies was estimated. c Number of colonies obtained on the twelve independent guide RNA multipartite assembly reactions
Fig. 2Targeted mutagenesis using the CRISPR/Cas9 system in transient expression in N. benthamiana. a Schematic representation of the structure of Niben101Scf04205Ctg025 (XT1) and Niben101Scf04551Ctg021 (XT2) (exons in grey, introns in white) with the sequences of the target sites. Diagnostic restriction sites are underlined and the PAM sequence is shown in bold. b Comparison of the mutation efficiency of hCas9 and pcoCas9 targeting the XT2. Red arrow shows SpeI resistant PCR fragments only visible on the gRNA and hCas9 combination. c PCR/RE assay to detect simultaneous targeted mutations on XT1 and XT2. Red arrows show BsmBI and SpeI resistant PCR fragments amplified from N. benthamiana genomic DNA. d Alignment of XT1 and XT2 sequences obtained from different clones of uncleaved bands (see c). XT1 target site appears in blue and XT2 target site in green. Red letters and dashes indicate insertions and deletions respectively
Fig. 3Transcriptional repression of the nopaline synthase promoter (pNOS) with different variants of the dead Cas9. a Schematic representation of the gRNA target positions on the pNOS. The gRNAs were selected in both sense and antisense strands. In parenthesis the 5′ position of each gRNA according to the pNOS transcription start site. b Comparison of the repression rates mediated by the different gRNAs combinations targeting the pNOS in combination with the dCas9. c Repression rates of the dCas9:BRD and dCas9:SRDX in combination with gRNAs targeting different positions upstream the pNOS TATA-box. d Influence of the presence of the BRD domain fused to the dCas9 on the repression levels induced by gRNAs 1, 2 and 4. All values were normalized to the Fluc/Rluc ratios of a reference sample set as 1. Bars represent average values of three samples ± SD
Fig. 4Transcriptional activation and modulation of the nopaline synthase promoter (pNOS). a Fluc/Rluc ratios obtained with dCas9:VP64 and dCas9:EDLL in combination with gRNAs 3, 4 and 5. b Comparison of the Fluc/Rluc ratios obtained for gRNAs 3, 4 and 5 in combination with the different dCas9 variants reported on this work. All values were normalized to the Fluc/Rluc ratios of the reference sample set as 1. Bars represent average values of three samples ± SD
Fig. 5Second dimension Multiplexing with Goldenbraid. a Pipeline of the 2D multiplexing strategy. Targets are designed as level 0 structures and combined with standard level −1 parts to create individual oligomers that are combined in level 1 polycistronic tRNA–gRNA structures. The binary combination of two polycistrons incorporates a 2D multiplexing step on the CRISPR cloning workflow. b Restriction analysis of two clones of level 1 polycistronic structures targeting fucosyl (Lanes 1 and 2; EcoRI expected bands: 6345-796) and xylosyltransferases (Lanes 3 and 4; HindIII expected bands: 6345-623), two clones of a level 2 construct derived from their binary assembly (Lanes 5 and 6; BamHI expected bands: 6674-1401) and two clones of its assembly with the hCas9 (Lanes 7 and 8; BsmBI expected bands: 7215-6367)